Machine-learning screening identified experimentally active pore-forming peptides
Machine-learning models and membrane-related filters were used to prioritize natural peptide sequences for testing. The study reports seven experimentally active peptides; three showed broad-spectrum activity and pore-forming evidence in the reported membrane assays. Peptide 615 had already been disclosed in a Peking University patent published in March 2025, before the related preprint and journal article. This entry represents one study campaign and makes no first-disclosure or sequence-novelty claim. Assay results do not establish clinical safety or efficacy.
Technology: ProtBERT-BFD sequence embeddings with a support-vector classifier and membrane-interaction, secondary-structure and contact-map predictions
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The paper reports seven experimentally active selected peptides and pore-forming measurements for three broad-spectrum candidates.
- Still unknown: One peptide sequence, 615, was disclosed in an earlier university patent. The article does not establish clinical safety or efficacy, and no universal mechanism is claimed.
- AI role: Machine-learning sequence and membrane-related models prioritized peptide candidates for experimental testing.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12904036/ · https://patents.google.com/patent/CN119591677A/zh · https://doi.org/10.1101/2025.05.17.654650
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary PMC full text, metadata and affiliation block; published patent text for earlier public disclosure; primary preprint record identified in the frozen source review..
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.